120
Participants
Start Date
January 17, 2024
Primary Completion Date
April 2, 2026
Study Completion Date
April 2, 2026
Non-Interventional
No study treatment will be administered in this study.
RECRUITING
Children's Hospital of Philadelphia (CHOP), Philadelphia
RECRUITING
Georgetown University Medical Center, Washington D.C.
RECRUITING
University Hospital Hamburg Eppendorf, Hamburg
RECRUITING
University of Florida, Gainesville
RECRUITING
Vanderbilt University Medical Center, Nashville
RECRUITING
Nationwide Children's Hospital, Columbus
RECRUITING
University Hospitals Cleveland Medical Center, Cleveland
RECRUITING
Indiana Hemophilia and Thrombosis Center, Indianapolis
RECRUITING
University of Michigan, Ann Arbor
RECRUITING
Klinikum der Johann Wolfgang Goethe-Universitaet Frankfurt, Frankfurt
RECRUITING
Rush University Medical Center, Chicago
RECRUITING
University of Texas Health Science Center at Houston, Houston
RECRUITING
University of Colorado Hemophilia and Thrombosis Center, Aurora
COMPLETED
Orthopaedic Hemophilia Treatment Center, Los Angeles
RECRUITING
University Hospital of Regensburg, Regensburg
RECRUITING
Yale HTC, New Haven
RECRUITING
McMaster University Medical Centre - Hamilton Health Sciences, Hamilton
RECRUITING
Mcgill University Health Center (MUHC), Montreal
RECRUITING
Southampton General Hospital, Southampton
RECRUITING
Glasgow Royal Infirmary - Clinical Research Facility, Glasgow
RECRUITING
Barts Health NHS Trust, Royal London Hospital, London
RECRUITING
St. Thomas' Hospital, London
Regeneron Pharmaceuticals
INDUSTRY